[1]张 挺.厄贝沙坦联合美托洛尔治疗慢性充血性心衰的疗效观察[J].医学信息,2018,31(05):125-127.[doi:10.3969/j.issn.1006-1959.2018.05.044]
　ZHANG Ting.Efficacy of Irbesartan Combined with Metoprolol in the Treatment of Chronic Congestive Heart Failure[J].Journal of Medical Information,2018,31(05):125-127.[doi:10.3969/j.issn.1006-1959.2018.05.044]
点击复制

厄贝沙坦联合美托洛尔治疗慢性充血性心衰的疗效观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年05期
页码:
125-127
栏目:
药物与临床
出版日期:
2018-03-01

文章信息/Info

Title:
Efficacy of Irbesartan Combined with Metoprolol in the Treatment of Chronic Congestive Heart Failure
文章编号:
1006-1959（2018）05-0125-03
作者:
张 挺
一五七医院干诊科，辽宁 沈阳 110045
Author(s):
ZHANG Ting
Department of Dry Diagnosis,157 Hospital,Shenyang 110045,Liaoning,China
关键词:
厄贝沙坦; 美托洛尔; 慢性充血性心衰
Keywords:
Key words：Irbesartan; Metoprolol; Chronic congestive heart failure
分类号:
R541.6
DOI:
10.3969/j.issn.1006-1959.2018.05.044
文献标志码:
A
摘要:
目的 观察厄贝沙坦联合美托洛尔治疗慢性充血性心衰的临床疗效。方法 选择我院自2015年3月~2016年5月收治68例慢性充血性心衰患者作为研究对象，将其随机分成对照组和研究组，每组34例。对照组采用厄贝沙坦治疗，研究组采用厄贝沙坦联合美托洛尔治疗，比较两组患者治疗前后的心率（HR）、收缩压（SBP）和舒张压（DBP）等血压水平以及左室舒张末内径（LVEDd）、左室收缩末内径（LVESd）和左室射血分数（LVEF）等左心功能指标，并统计和计算两组患者治疗期间的不良反应发生率及治疗的总有效率。结果 两组患者治疗前的心率、血压及各项左心功能水平对比，差异均无统计学意义（P＞0.05）。治疗期间，研究组与对照组的不良反应发生率对比差异统计学意义（P＞0.05）。治疗后，研究组的HR、DBP、DBP、LVEDd、LVESd均明显低于对照组，研究组的LVEF、治疗的总有效率明显高于对照组，两组对比差异有统计学意义（P＜0.05）。结论 对慢性充血性心衰患者采用厄贝沙坦联合美托洛尔治疗，不仅能有效改善患者的心率和血压水平，同时还能有效促进患者的左心功能恢复，患者治疗期间的毒副反应发生率较低，因此其是一组安全、高效的组合治疗药物。
Abstract:
Abstract：Objective To observe the clinical efficacy of irbesartan combined with metoprolol in the treatment of chronic congestive heart failure.Methods 68 patients with chronic congestive heart failure from March 2015 to May 2016 were randomly divided into control group(n=34)and study group(n=34).The control group was treated with irbesartan and the study group with irbesartan combined with metoprolol.Before and after treatment,the blood pressure levels,such as heart rate(HR),systolic blood pressure(SBP)and diastolic blood pressure(DBP),left ventricular end-diastolic diameter(LVEDd),left ventricular end-systolic diameter (LVESd)and left ventricular ejection fraction(LVEF)were compared between the two groups.The incidence of adverse reactions during treatment and the total effective rate of treatment were counted and calculated.Results There was no significant difference in heart rate,blood pressure and left ventricular function between the two groups before treatment(P>0.05).During the treatment period,the incidence of adverse reactions in the study group and the control group was significantly different(P>0.05).After treatment,the HR,DBP,DBP,LVEDd and LVESd in the study group were significantly lower than those in the control group.The total effective rate of LVEF and treatment in the study group was significantly higher than that in the control group,the difference between the two groups was statistically significant(P<0.05).Conclusion Irbesartan combined with metoprolol in patients with chronic congestive heart failure can not only improve the heart rate and blood pressure,but also promote the recovery of left ventricular function.The incidence of side effects during treatment is low,so it is a safe and effective combination of drugs.

参考文献/References:

[1]徐翔.联合应用厄贝沙坦及美托洛尔对慢性充血性心衰的疗效分析[J].首都食品与医药,2016,23(14):50. [2]徐时平,朱琳莲,潘小进,等.厄贝沙坦结合美托洛尔治疗慢性充血性心衰患者的疗效研究[J].中外医疗,2015,34(12):101-102. [3]吴静.美托洛尔联合厄贝沙坦治疗慢性充血性心衰80例临床研究[J].现代诊断与治疗,2016,27(19):3584-3585. [4]黎琳.替米沙坦联合美托洛尔治疗慢性充血性心衰的疗效观察[J].中国处方药,2017,15(02):7-8. [5]沈志杰.厄贝沙坦联合美托洛尔治疗慢性充血性心衰的疗效观察[J].海峡药学,2017,29(03):156-157. [6]李敬梅.厄贝沙坦联合美托洛尔治疗慢性充血性心衰的效果观察[J].中外医学研究,2017,15(21):33-34. [7]陈晓勇,张伶俐,林紫薇.厄贝沙坦联合美托洛尔治疗慢性充血性心衰的疗效观察[J].中国现代医生,2017,55(18):88-90. [8]艾尼瓦尔·阿不力孜,赵景贺.厄贝沙坦与美托洛尔对慢性充血性心衰的治疗效果研究[J].心血管病防治知识(学术版),2016(02):67-68.

相似文献/References:

[1]郑 磊.美托洛尔联合卡托普利对慢性心衰患者心肌重构及心功能的影响分析[J].医学信息,2018,31(03):130.[doi:10.3969/j.issn.1006-1959.2018.03.045]
　ZHENG Lei.Effect of Metoprolol Combined with Captopril on Myocardial Remodeling and Cardiac Function in Patients with Chronic Heart Failure[J].Journal of Medical Information,2018,31(05):130.[doi:10.3969/j.issn.1006-1959.2018.03.045]
[2]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
　ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Journal of Medical Information,2018,31(05):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[3]孙洪艳.硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的疗效观察[J].医学信息,2018,31(10):131.[doi:10.3969/j.issn.1006-1959.2018.10.043]
　SUN Hong-yan.Efficacy of Nifedipine Combined with Irbesartan in the Treatment of Diabetes Complicated with Hypertension[J].Journal of Medical Information,2018,31(05):131.[doi:10.3969/j.issn.1006-1959.2018.10.043]
[4]张红新.归脾汤联合美托洛尔治疗冠心病合并心律失常的效果及预后[J].医学信息,2019,32(04):156.[doi:10.3969/j.issn.1006-1959.2019.04.051]
　ZHANG Hong-xin.Effect and Prognosis of Guipi Decoction Combined with Metoprolol in the Treatment of Coronary Heart Disease Complicated with Arrhythmia[J].Journal of Medical Information,2019,32(05):156.[doi:10.3969/j.issn.1006-1959.2019.04.051]
[5]董选忠.美托洛尔联合稳心颗粒治疗心律失常的临床疗效及安全性分析[J].医学信息,2018,31(21):137.[doi:10.3969/j.issn.1006-1959.2018.21.039]
　DONG Xuan-zhong.Clinical Efficacy and Safety Analysis of Metoprolol Combined with Wenxin Granule in the Treatment of Arrhythmia[J].Journal of Medical Information,2018,31(05):137.[doi:10.3969/j.issn.1006-1959.2018.21.039]
[6]纪东华,宁国贤.贝那普利联合美托洛尔治疗CHF的效果及对心室重构影响[J].医学信息,2019,32(14):156.[doi:10.3969/j.issn.1006-1959.2019.14.052]
　JI Dong-hua,NING Guo-xian.Effect of Benazepril Combined with Metoprolol on Ventricular Remodeling in Patients with CHF[J].Journal of Medical Information,2019,32(05):156.[doi:10.3969/j.issn.1006-1959.2019.14.052]
[7]纪东华.曲美他嗪治疗老年冠心病心力衰竭的疗效及其对患者 炎症因子的影响[J].医学信息,2019,32(13):141.[doi:10.3969/j.issn.1006-1959.2019.13.043]
　JI Dong-hua.Efficacy of Trimetazidine in the Treatment of Elderly Patients with Coronary Heart Disease and Its Effect on Inflammatory Factors[J].Journal of Medical Information,2019,32(05):141.[doi:10.3969/j.issn.1006-1959.2019.13.043]
[8]孙 健.小剂量胺碘酮与美托洛尔治疗老年性房颤的效果及对左心房和心功能的影响[J].医学信息,2022,35(18):105.[doi:10.3969/j.issn.1006-1959.2022.18.028]
　SUN Jian.The Effect of Low-dose Amiodarone and Metoprolol in the Treatment of Senile Atrial Fibrillation and its Effect on Left Atrial and Cardiac Function[J].Journal of Medical Information,2022,35(05):105.[doi:10.3969/j.issn.1006-1959.2022.18.028]
[9]鲍江波.肾炎康复片联合厄贝沙坦治疗慢性肾炎蛋白尿的临床效果[J].医学信息,2020,33(13):162.[doi:10.3969/j.issn.1006-1959.2020.13.050]
　BAO Jiang-bo.Clinical Effect of Nephritis Rehabilitation Tablets Combined with Irbesartan on Proteinuria of Chronic Nephritis[J].Journal of Medical Information,2020,33(05):162.[doi:10.3969/j.issn.1006-1959.2020.13.050]
[10]桑明敏,朱芳一,祝存奎,等.芪参益气滴丸联合美托洛尔治疗原发性高血压病合并慢性心衰的疗效[J].医学信息,2020,33(21):157.[doi:10.3969/j.issn.1006-1959.2020.21.049]
　SANG Ming-min,ZHU Fang-yi,ZHU Cun-kui,et al.Effect of Qishen Yiqi Dropping Pills and Metoprolol in the Treatment of Essential Hypertension with Chronic Heart Failure[J].Journal of Medical Information,2020,33(05):157.[doi:10.3969/j.issn.1006-1959.2020.21.049]

更新日期/Last Update: 2018-03-01